TABLE 1.
Demographic and biochemical characteristics of men and women in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study (n = 920)
| Men (n = 441) | Women (n = 479) | P | |
| Age (y) | 49 ± 161 | 49 ± 16 | 0.8142 |
| BMI (kg/m2) | 28.6 ± 4.8 | 28.3 ± 6.4 | 0.3142 |
| Systolic blood pressure (mm Hg) | 119 ± 14.9 | 113 ± 197.9 | <0.0012 |
| Diastolic blood pressure (mm Hg) | 71 ± 8.9 | 66 ± 9.1 | <0.0012 |
| Total cholesterol (mmol/L) | 4.95 ± 0.99 | 5.00 ± 1.07 | 0.4352 |
| LDL cholesterol (mmol/L) | 3.22 ± 0.78 | 3.13 ± 0.86 | 0.0692 |
| HDL cholesterol (mmol/L) | 1.07 ± 0.25 | 1.35 ± 0.36 | <0.001 |
| Triglyceride (mmol/L) | 1.68 ± 0.91 | 1.40 ± 0.81 | 0.0012 |
| Current smokers [n (%)] | 37 (8) | 41 (9) | 0.9183 |
| Current alcohol drinkers [n (%)] | 219 (50) | 229 (48) | 0.6443 |
| Treatment of diabetes [n (%)] | 20 (5) | 23 (5) | 0.8773 |
| Treatment of hypertension [n (%)] | 87 (20) | 80 (17) | 0.2663 |
| Treatment to lower lipids [n (%)] | 24 (5) | 13 (3) | 0.0433 |
| Hormone treatment [n (%)] | — | 96 (20) | <0.0013 |
| Prior coronary heart disease [n (%)] | 43 (10) | 11 (2) | <0.0013 |
1
Mean ± SD (all such values).
2
ANOVA.
3
Chi-square test.